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ABSTRACT 
Background: Tissue defects in the vocal fold (VF) caused by trauma, surgical procedures, post 
radiotherapy often heal with scar formation. The scar tissue causes stiffness of the lamina propria 
rendering disturbed viscoelastic properties to the VF. A scarred VF causes severe voice problems. 
Treatment is difficult and presently there is no treatment that heals VF scars. 
Objectives: The aims of this thesis were to evaluate if human stem cell transplantations have the 
potential to heal scarred VFs, and if transplanted stem cells regenerate lost tissue in scarred VFs. 
Study Design: Experimental xenograft model. 
 
Methods: The VFs of New Zealand rabbits were scarred by a 1.5–2 mm resection. Human embryonic 
(hESCs) or mesenchymal (hMSCs) stem cells were thereafter transplanted into the VFs. Analyses for 
grade of scaring, lamina propria (Lp) thickness, relative content of collagen type I, elastic and dynamic 
viscoelasticity (G', '), fluorescence in situ hybridisation for detection of human cells, Verhoeff 
staining for detection of elastin, alcian blue staining for detection of hyaluronic acid, RT-PCR species-
specific analysis for collagen type I, and for Nanog expression of pluripotency were performed. 
Results: Both transplanted hESCs (G’)(') and hMSCs (G’) significantly improved the viscoelastic 
properties of the VFs, analyzed at one month. HMSCs also significantly reduced collagen type I 
content. At three months hMSC treatment significantly reduced both (G’) (') and showed no 
significant differences to normal VFs. Also collagen type I content and Lp thickness were significantly 
reduced and were not significantly higher than in normal VFs. A clinic like setting was studied, where 
VFs were resected and left to spontaneously heal for 9 weeks. The established scar was thereafter 
excised, hMSCs transplanted in the wound, and the VFs were analyzed after another ten weeks. The 
hMSC transplanted VFs showed no significant difference in ', nor in G', nor in Lp-thickness 
compared to normal VFs, and all three parameters were significantly reduced compared with untreated 
scarred VFs. 
The transplanted hESCs showed after one month, by differentiation, regeneration of epithelium, 
muscle, cartilage and gland tissue in contact with corresponding rabbit native tissue. HMSCs did not 
differentiate or regenerate tissue. Pluripotent hESCs were shown to survive one month, and hMSCs 
survived four but not ten weeks in the rabbit VFs. The transplanted VFs showed no malignancy or 
teratoma formation.  
The immunosuppressant Tacrolimus used to reduce the host versus graft reaction suppressed the anti-
scaring effect of the transplanted hMSCs. 
Conclusion: Both human embryonic and mesenchymal stem cells have the potential to improve 
healing and to restore the rheological properties of scarred VFs. Human embryonic stem cells 
transplanted into scarred rabbit vocal folds differentiate and regenerate human tissue compatible with 
the surrounding native tissue. 
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